Support NorthStar News - Make a Donation

video icon  Video of the Week

US to hold direct peace talks with Taliban

Search Past Issues

May 3, 2012

Erectile Dysfunction Picture

FDA Approves Fast-Acting Drug to Treat Erectile Dysfunction

The U.S. Food and Drug Administration (FDA) has approved a new, fast-acting drug to treat erectile dysfunction. An estimated 30 million men in the United States have difficulty achieving and maintaining an erection.

The drug, Stendra, helps increase the blood flow to the penis in 30 minutes. The website WebMD reported, however, that Stendra proved to be effective for some men in 15 minutes.

“This approval expands the available treatment options to men experiencing erectile dysfunction, and enables patients, in consultation with their doctor, to choose the most-appropriate treatment for their needs,” Dr. Victoria Kusiak, deputy director of the Office of Drug Evaluation III in the FDA's Center for Drug Evaluation and Research, said on April 27, the date Stendra's approval was announced.

During drug trials, Stendra resulted in successful intercourse for men suffering from diabetes-related erectile dysfunction, reported WebMD.

Stendra, which is manufactured by Vivus Inc., a Mountain View, Calif., biopharmaceutical company, is in the same class of drugs as Cialis, Levitra and Viagra that treat erectile dysfunction. 

Like other medications in this class, Stendra can cause side effects, including loss of hearing and vision in both eyes. Men who take nitrates to treat angina, or chest pain, should not take Stendra because it causes a drop in blood pressure.

The Northstar News & Analysis, Inc.
Chicago, IL | 312.504.0223
Copyright © The Northstar News & Analysis, Inc.
Contact Us: info@TheNorthstarNews.com
Privacy Policy

My statusContact Us on Skype